Additionally, thiazolidinedione insulin sensitizers, peroxisome proliferator-activated receptors, glucagon receptor antagonists, and dipeptidyl peptidase IV inhibitors are being used as therapeutic regimens to manage DM [36]. The gene discussed is INS; the disease is diabetes mellitus.